NCT01576874View on ClinicalTrials.gov

The Gender-Sex Hormone Interface With Craving & Stress-Related Changes in Smoking

NACompletedINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

May 31, 2017

Study Completion Date

June 30, 2017

Conditions
Nicotine Dependence
Interventions
DRUG

Oxytocin

40 IUs of oxytocin administered intranasally one time

DRUG

placebo

placebo administered intranasally one time

Trial Locations (1)

29425

Medical University of South Carolina, Charleston

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Kevin Gray, MD

OTHER

NCT01576874 - The Gender-Sex Hormone Interface With Craving & Stress-Related Changes in Smoking | Biotech Hunter | Biotech Hunter